Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ALMS1 |
| Upstream (Parents) |
|---|
| (<<) UBQLN4 → ALMS1 |
| (<<) NRIP1 → ALMS1 |
| (<<) ZNF45 → ALMS1 |
| (<<) SOCS6 → ALMS1 |
| (<<) NACAP1 → ALMS1 |
| Downstream (Children) |
|---|
| ALMS1 → TIMM17A (>>) |
| ALMS1 → BTG4 (>>) |
| ALMS1 → LOC51145 (>>) |
| ALMS1 → LOC100132247///LOC730153///LOC729978///LOC729602///LOC642799///LOC641298///NPIPL1///NPIPL3 (>>) |
| ALMS1 → NANOG (>>) |
| ALMS1 → LOC727787///KIR3DL2 (>>) |
| ALMS1 → SHOX (>>) |
| ALMS1 → ME1 (>>) |
| ALMS1 → TAS2R1 (>>) |
| ALMS1 → GKN1 (>>) |
| ALMS1 → FEZ1 (>>) |
| ALMS1 → KLHL1 (>>) |
| ALMS1 → ARL17A (>>) |
| ALMS1 → HECW1 (>>) |
| ALMS1 → LAT2 (>>) |
| ALMS1 → ADORA1 (>>) |
| ALMS1 → ZNF500 (>>) |
| ALMS1 → UBQLN4 (>>) |
| ALMS1 → C1orf61 (>>) |
| ALMS1 → ALPK1 (>>) |
| ALMS1 → PRLH (>>) |
| ALMS1 → ARHGEF15 (>>) |
| ALMS1 → NEUROD4 (>>) |
| ALMS1 → NACAP1 (>>) |
